In both liver cancer cell lines, the level of Bcl-2 an Bcl-xL were substantially altered at 6.25 μg/ml PCC with further down-regulation observed at 12.5 and 25 μg/ml (Fig. 12). The gene discussed is BCL2L1; the disease is liver cancer.